You haven't searched anything yet.
PET Radiochemist
- (3290905)
GENERAL SUMMARY/ OVERVIEW STATEMENT:
The Staff PET Radiochemist is principally responsible for the routine production and quality control of novel and literature radiotracers for clinical and pre-clinical use at BWH cyclotron and associated radiochemistry facilities (BWH-BICOR) within the Division of Nuclear Medicine & Molecular Imaging.
This position acts as an assistant to the Director of Radiochemistry Research & Development in the implementation and optimization of radiochemical syntheses and analytical methods to support candidate novel and literature molecular imaging biomarkers for clinical and preclinical use. Additionally, the Staff PET Radiochemist may develop and compose CMC documentation in collaboration with the Director of Radiochemistry R&D for inclusion in US FDA IND applications.
The incumbent, being recognized as a qualified aseptic PET GMP operator, is also responsible for supporting the routine production of FDA-approved radiopharmaceuticals by the BWH-BICOR in all facets of the operation, when able, inclusive of synthesis, quality control, ISO-classified cleanroom management, and raw material control in accordance with applicable regulatory guidelines and hospital policy. The Staff PET Radiochemist must have above average to superior working knowledge of principles related to chemical syntheses and analytical methodology commonly utilized in radiolabeling and radiopharmaceutical manufacturing processes. Reports to the BICOR Director with dotted line to Director of Radiochemistry R&D
PRINCIPAL DUTIES AND RESPONSIBILITIES:
The major responsibility of this position is to routinely produce the highest quality radiopharmaceuticals and radiotracers for human use on a regular basis with full regulatory compliance. This involves but is not limited to:
SKILLS/ABILITIES/COMPETENCIES REQUIRED
Full Time
Ambulatory Healthcare Services
$134k-159k (estimate)
05/22/2024
07/20/2024
brighamandwomens.org
BOSTON, MA
7,500 - 15,000
1994
KARL H BREUING MD
$1B - $3B
Ambulatory Healthcare Services